Detalhe da pesquisa
1.
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.
Mol Cell
; 71(4): 606-620.e7, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30118680
2.
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer.
J Biol Chem
; 298(4): 101817, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278434
3.
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.
Mol Cancer
; 21(1): 185, 2022 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36163179
4.
Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma.
J Hepatol
; 74(4): 907-918, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031845
5.
The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis.
J Biomed Sci
; 27(1): 77, 2020 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620165
6.
Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma.
Haematologica
; 108(5): 1412-1416, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36475521
7.
A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases.
J Biomed Sci
; 25(1): 83, 2018 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30449278
8.
Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial.
Future Oncol
; 14(6): 515-525, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29119833
9.
Erratum to 'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma' [J Hepatol 2021 (907-918)].
J Hepatol
; 77(2): 580, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489965
10.
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.
Nat Commun
; 15(1): 1009, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307859
11.
The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.
Exp Hematol Oncol
; 13(1): 14, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38326887
12.
Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2.
J Biol Chem
; 287(20): 16869-79, 2012 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22451678
13.
Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation.
Int J Biol Sci
; 19(10): 2957-2973, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37416781
14.
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
J Immunother Cancer
; 11(10)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793852
15.
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.
Cell Death Dis
; 14(11): 714, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919300
16.
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.
J Clin Invest
; 133(3)2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719376
17.
An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response.
STAR Protoc
; 3(1): 101198, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243381
18.
De-glycosylated membrane PD-L1 in tumor tissues as a biomarker for responsiveness to atezolizumab (Tecentriq) in advanced breast cancer patients.
Am J Cancer Res
; 12(1): 123-137, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141008
19.
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.
Nat Cancer
; 3(10): 1211-1227, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253486
20.
The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus.
J Biol Chem
; 285(49): 38720-9, 2010 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20937808